Background: Chronotropic incompetence (CI) is a marker of poor prognosis in patients with COPD. Treatments that improve pulmonary function and exercise capacity may affect CI. Objectives are to evaluate CI before and after lung volume reduction surgery (LVRS) and determine if changes in CI are associated with changes in pulmonary function and exercise capacity. Methods: We performed a retrospective review of 75 patients who underwent LVRS and who had complete cardiopulmonary exercise testing and concurrent pulmonary function tests two months before and about 6 months after surgery. Additionally we evaluated 28 control patients that were randomized to medical treatment as part of the National Emphysema Treatment Trial at our center. We studied CI using the percent of predicted heart rate reserve Z (heart rate peak À heart rate rest)/((208 À 0.7 Â age) À heart rate rest) Â 100, before and after surgery and compared it to the control group. Results: Mean percent of predicted heart rate reserve improved from 41% to 50% (p-value <0.001) after LVRS, while the control group did not change. The mean forced vital capacity and expiratory volume in 1 s, peak oxygen consumption, carbon dioxide production, ventilation, tidal volume and maximal workload all improved in the surgery group, while the controls did not improve. (M.E. Ginsburg), aml2135@columbia.edu (A.M. Layton), bmt1@columbia.edu (B.M. Thomashow), mnb4@ columbia.edu (M.N. Bartels). 0954-6111/$ -see front matter ª Respiratory Medicine (2012) 106, 1389e1395
Introduction
Chronic obstructive pulmonary disease (COPD) is now the third leading cause of death in the United States, 1 and lung volume reduction surgery (LVRS) has been shown to be an effective treatment for a subset of patients with severe emphysema. In appropriately selected patients, LVRS can decrease morbidity, mortality 2,3 and dyspnea, while improving exercise performance, 4,5 endurance, 6 pulmonary function, 4 and quality of life. 5 While many of these benefits likely represent improvements in pulmonary mechanics, 7 improvements in cardiovascular function have also been postulated to play a role. 8 Recently, in a population-based study of normal patients and those with mild COPD, Barr et al. showed that the degree of airflow obstruction is significantly associated with reduced left ventricular end-diastolic volume, stroke volume and cardiac output. 9 Additionally, it has been shown that hyperinflation is significantly associated with impaired left ventricular filling and right ventricular dysfunction and that the impaired left ventricular filling is independently associated with decreased exercise tolerance. 10, 11 As these studies imply, the degree to which impaired cardiac function can be augmented by reducing hyperinflation may have implications in patient care. 10 Chronotropic incompetence (CI), or an attenuated heart rate (HR) response to exercise, has the highest prevalence among individuals with the most impaired exercise capacity 12 but CI is also seen in healthy obese subjects, healthy smokers, 13, 14 and patients with COPD. 14e16 Treatments that improve pulmonary function, such as LVRS, may have a secondary benefit on improving cardiac function and thus also improving CI. To address this uncertainty, the current study was designed using cardiopulmonary exercise testing (CPET) parameters to investigate the effect of LVRS on CI in a group of patients with emphysema. To evaluate our hypothesis we had a specific aim to evaluate the effect of LVRS on CI compared to controls that had no surgery but continued maximal medical care.
Materials and methods

Patients
The Institutional Review Board of the New York Presbyterian, Columbia University Medical Center approved this study. A retrospective chart review was performed on all patients who had undergone LVRS at Columbia University Medical Center from January 1998 to October 2009. Patients who had CPET and pulmonary function tests (PFT) within 2 months before LVRS and repeat testing approximately 6 months after were included. PFTs concurrent with CPET were chosen. The patients underwent rehabilitation, performed the first CPET 2 months before LVRS, underwent post-surgery rehabilitation and then performed the second CPET six months after LVRS.
In order to rule out the possible effects of the intensive pre-and post-LVRS pulmonary rehabilitation given to the patients, we analyzed the National Emphysema Treatment Trial (NETT) patients that were randomized to medical treatment (which included pulmonary rehabilitation) at our center.
Exercise and pulmonary function testing
CPET was performed on an electronically braked cycle ergometer (Ergometrics 800, SensorMedics Inc., Yorba Linda, CA) with a Viasys Sensormedics Encore metabolic cart (Viasys Corporation, Loma Linda, CA); prior to 2005 a Vmax 229 series workstation (SensorMedics Inc., Yorba Linda, CA) was used. Continuous 12-lead telemetry was monitored via CardioSoft electrocardiogram software (GE/ CardioSoft, Houston, TX); prior to 2005 a model Max-1 electrocardiogram was used (Marquette Medical Systems; Milwaukee, WI). Oxygen saturation was recorded with a N595 pulse oximeter (Nellcor, Boulder, CO); prior to 2005 a Sensormedics Sat-Trak (SensorMedics Inc., Yorba Linda, CA) was used. All patients were tested on 30% fractional inspired oxygen via mouthpiece both before and after LVRS. The exercise protocol was ramping and followed the protocol used in the NETT 3 and American Thoracic Society guidelines. 17, 18 The same ramp was used at baseline and at the 6 month CPET. CPET variables were collected breath by breath and included rate of carbon dioxide production (VCO 2 ), maximal workload (peak watts), oxygen consumption by weight (VO 2 in mL/kg/min), percent of predicted oxygen consumption attained (VO 2 %), minute ventilation (VE), tidal volume (Vt), respiratory rate (RR), end-tidal CO 2 pressure (PetCO 2 ), HR at baseline (HR rest ), heart rate at peak exercise (HR max ), systolic blood pressure at baseline and at peak exercise (SBP rest and SBP max ) and diastolic blood pressure at baseline and at peak exercise (DBP rest and DBP max ). All PFTs were performed according to the NETT protocol. 3 This included the forced vital capacity (FVC), forced expiratory volume in 1 s (FEV 1 ), total lung capacity (TLC), and residual volume (RV). Percent of predicted PFTs was calculated for males and females as described in prior publications. 19e21 Age predicted peak HR was calculated using 208 À 0.7 Â age. 22 CI was assessed using the percent of predicted heart rate reserve (%HRR)Z(HR max À HR rest )/ ((age predicted HR) À HR rest ) Â 100. 23 A %HRR below 80% in the absence of beta-blocker therapy is considered abnormal and shown to be a predictor of mortality. 16, 23 PFT and CPET values before LVRS were compared to the values after to determine the effects of LVRS on pulmonary function, HR and peak exercise capacity.
Statistics
Data were analyzed with SPSS version 18 (SPSS, Chicago, IL). The distribution of the variables was assessed using the KolmogoroveSmirnov test. Variables that were normally distributed are presented as mean AE standard deviation. Variables that deviated from normal are presented as median and interquartile range (IQR) (25%, 75%). Continuous variables were analyzed with paired-samples t-test. Analysis of group differences for non-normally distributed variables was analyzed with the Wilcoxon matched-pair signed rank test. Pearson's correlations were used to determine the associations between variables. Independent samples t-test was used to assess differences between those included and not and between the control and surgery groups. Statistical significance was set at p 0.005 since multiple comparisons were performed.
Results
Patients
Of 125 patients who had undergone LVRS between 1998 and 2009, 82 patients had PFT and CPET data before and after LVRS. The median time between the first CPET and surgery was 39 (15, 67) days while the median time between surgery and the second CPET was 195 (176, 220) days. Despite our usual practice to perform CPET both before and after surgery to assess function and help guide exercise programs, there was variability in practice before the NETT guidelines were established in 2004. Twenty-two patients had no CPET before LVRS, 17 patients had no CPET after LVRS due to loss of follow up and 4 patients died within 6 months of surgery. Three additional patients were excluded because the CPET before LVRS was done on room air instead of supplemental oxygen, and 4 had ischemic heart disease, leaving 75 (57% female, 63 AE 7 years old, BMI of 24 AE 5 kg/m 2 ) patients available for analysis. Twenty-five of these cases were performed as part of the NETT. There were no differences in terms of gender or age between those included and not included (data not shown). Medications were not significantly different between patients before and after surgery. Specifically, with regard to cardioactive medications, all patients were on beta agonist before and after surgery, with none on beta blockade, 97% of patients were on anticholinergic medications before and after surgery, 24% were on calcium channel blocker before surgery, only one additional patient started calcium channel blocker for peri-operative tachycardia, and 6% were on digitalis before and after surgery.
All patients were chronic ex-smokers who were confirmed abstinent from smoking for at least 6 months prior to and post-surgery. All patients had an electrocardiogram at the time of CPET and were in sinus rhythm. None had active ischemic heart disease by screening from dobutamine stress echocardiogram or thallium testing and cardiac catheterization for those patients with any suspicious changes on the dobutamine testing. Left ventricular ejection fraction (>45%) and absence of significant valvular disease was confirmed by review of echocardiogram or left heart catheterization closest to the time of the first CPET. The PFT parameters of the LVRS group before and after surgery can be seen in Table 1 . All PFT variables changed significantly. The mean FEV 1 % and FVC % increased while the TLC %, RV % and RV/TLC ratio decreased following LVRS.
Resting parameters
Slightly above our significance level but notable, the mean HR rest decreased from 89 bpm to 85 bpm (p Z 0.008) and the SBP rest decreased from 131 mmHg to 127 mmHg (p Z 0.007) after LVRS ( Table 2) .
Exercise parameters
The CPET variables that significantly improved following LVRS can be seen in Table 2 . The %HRR significantly improved from 41% to 50% after LVRS ( Fig. 1) , attributable to the decrease in HR rest and increase in HR max . Before LVRS, only one patient had a normal %HRR, after LVRS, three patients had a normal %HRR. The PetCO 2 significantly decreased with exercise, demonstrating decreased CO 2 retention. Slightly above significance but notable, the mean O 2 pulse peak (p Z 0.007) was higher, suggesting an improvement in stroke volume after LVRS.
Since the surgery group significantly increased their exercise capacity, we looked at %HRR during comparable workloads (iso-workload) before and after LVRS (Table 3) . Notably, the PetCO 2 , SBP and DBP all decreased while the Vt increased when matching for wattage. The HR trended to decrease from 118 bpm to 114 bpm (p Z 0.015).
Correlations
Additionally we looked at the Pearson's correlation for percent change of each variable with change in %HRR. For example, the percent change in watts would be calculated as: (after LVRS watts À before LVRS watts)/before LVRS watts Â 100. The peak VO 2 , VE, and VCO 2 all significantly correlated with the change in %HRR (r Z 0.474, 0.498, and 0.506, respectively; p < 0.001 all). Just above significance, 
Control group
Our control group consisted of 28 patients (39% female, 66 AE 6 years old, BMI of 24.2 AE 3.3 kg/m 2 ) from the NETT that had similar severity of disease and were randomized to medical treatment and pulmonary rehabilitation at our center. All controls underwent the same screening (sinus rhythm, ischemic heart disease, etc.) as the surgery group. Medications were not significantly different between controls at baseline and second test. Specifically, with regard to cardioactive medications, all controls were on inhaled beta agonist and anticholinergic medications for both tests, with none on beta blockade or calcium channel blockade, and 12% were on digitalis for both tests. A comparison of the LVRS and control group is shown in Table  4 . There were no significant differences between the surgery and control groups in terms of age, gender, BMI or PFT variables. There was a difference in the peak VO 2 % predicted and significant difference in breathing reserve with the LVRS group having a lower VO 2 and a higher breathing reserve. At the second CPET and PFT, the TLC % and RV % significantly decreased as seen in Table 5 . However, there were no significant changes in any of the exercise capacity variables or iso-workload variables (data not shown). CI as measured by %HRR also did not change (first CPET %HRR: Figure 1 Boxplot shows that the %HRR significantly improved from a median (IQR) of 40% (30e52%) to 48% (34e64%) (p < 0.001). control group, during the first CPET, three patients had a normal %HRR and on the second CPET none of the patients had a normal %HRR.
Discussion
The main finding of this study is that LVRS improved CI, as measured by %HRR, in a group of patients with severe emphysema compared to similar control patients. In order to exclude the possible effects of pre-and post-LVRS pulmonary rehabilitation, the control group was selected from patients that were randomized to medical therapy from the NETT at our center. Before undergoing LVRS, the entire cohort (both patients and controls) had a mean %HRR of approximately 40e45%. After LVRS, the patients' %HRR significantly improved from 41% to 50%. In comparison, %HRR did not improve for the control group that underwent pulmonary rehabilitation and maximal medical care. Additionally, the mean PFT and CPET variables for the 75 patients analyzed also improved, which is in agreement with prior studies. 3,5,24e27 While other studies have looked at CI in patients with COPD, 14e16 to the best of our knowledge, this is the first to look at the effect of LVRS on CI. The cause of this improvement may include improved exercise capacity but may also have a component of alteration of autonomic tone due to improved lung function. Patients with COPD can demonstrate a number of sympathetic nervous system abnormalities that are thought to be related to alterations of ventilatory mechanics with subsequent cardiopulmonary changes, including increased pulmonary vascular resistance, increased right ventricular after load, and reduced right ventricular filling. 25,28e30 These abnormalities may increase sympathetic activity at rest and during exercise, as there is decreased stroke volume with alterations in cardiac output and right ventricular ejection fraction. 24,28,31e33 One could speculate that a proportion of the improvements in CI following LVRS may in part be related to decreased sympathetic tone at rest with lower HR rest and improved HR max along with changes in cardiac output, stroke volume, and right ventricular function, 24, 25 all allowing increased exercise performance. We also found improvements in PetCO 2 after LVRS which may have improved autonomic tone through decreased central chemoreceptor stimulation. 34, 35 Similarly, an alteration of the pulmonary mechanics after LVRS may also have significant effects on autonomic modulation. Another mechanism for the observed improvement in CI after LVRS may be through the improvement in peak workload and the improvement in right ventricular function, shown in prior studies, 5, 6, 8, 25 as a result of the improved ventilatory mechanics. Additionally, the percent change in peak VO 2 and watts correlated with the change in %HRR, showing that the two changes were associated with each other. The exercise improvements are likely through a combination of improved VE, Vt, and breathing reserve with a reduced RV/TLC ratio (decreased hyperinflation) and PetCO 2 (decreased air trapping).
Additionally, the patients who underwent LVRS also improved their cardiac function. The HR rest , HR max and O 2 pulse peak all improved. Although higher HR max may be explained by an increase in overall exercise capacity, this cannot be extended to the decrease in HR rest . Jorgensen et al. documented augmentation in myocardial performance with increased stroke volume and work index and normalization of left ventricular end-diastolic dimensions and left ventricular filling after LVRS. 8 Although an indirect measure of stroke volume, we showed an increase in the O 2 pulse at peak exercise with improvement of CI from reduced HR rest and increased HR max , giving a significantly higher %HRR following LVRS. Possible mechanisms of stroke volume may increase following LVRS due to decreased external compression (pulmonary tamponade) from reduced hyperinflation and an increase in right 24, 36, 37 and left ventricular filling. 8 This effect may contribute to the decrease in HR rest seen in our study and is supported by the recent study by Barr et al with impaired left ventricular filling in even early COPD. 9 Evaluation at iso-workloads before and after LVRS confirmed the improvement in PetCO 2 , Vt, SBP and DBP. This is consistent with a lower work effort at a similar workload after LVRS. Although there were only small changes in iso-workload HR and %HRR, the demonstration of reduced SBP and DBP at similar workloads also indicates a lower work effort after LVRS.
The chief limitation of this study is that it is retrospective. This did not allow inclusion of all the cardiovascular or autonomic measurements that would have permitted better understanding of the underlying cardiac and hemodynamic changes after LVRS that may have been associated with improved CI. There may be a period bias between our control and part of our surgery group since our control group was only part of the NETT but our surgery group continued to 2009. Additionally, the baseline differences in VO 2 % predicted and breathing reserve between the control and patient groups are factors in which the two groups are not comparable. However, despite this, their %HRR at baseline was still similar. Since coronary artery disease, which is relatively common in patients undergoing LVRS, 38 has been associated with CI, we screened for it with thallium and echo dobutamine studies with follow-up angiography in patients with any abnormality and excluded subjects who had ischemic disease. The strengths of the study lie with the relatively large number of LVRS patients and the strong positive improvement in CI, a noninvasive cardiac measure, indicating that LVRS may have significant benefits beyond pulmonary improvements. A prospective analysis of patients undergoing LVRS with more complete cardiac evaluation may be able to assess if the improvements in CI after LVRS correspond with a decrease in cardiac events and mortality.
In conclusion, this is the first study to demonstrate a clear improvement of chronotropic incompetence after lung volume reduction surgery in emphysematous patients, associated with a decrease in resting heart rate and an increase in peak exercise heart rate. The pulmonary rehabilitation control group did not see any of these changes. This study further describes another known domain of cardiopulmonary impairment prior to surgery that improves as a positive response to the therapy of LVRS.
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